KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Current Taxes (2018 - 2025)

Ionis Pharmaceuticals (IONS) has 10 years of Current Taxes data on record, last reported at $101000.0 in Q3 2025.

  • For Q3 2025, Current Taxes rose 146.34% year-over-year to $101000.0; the TTM value through Sep 2025 reached $101000.0, up 146.34%, while the annual FY2024 figure was $34000.0, 98.42% down from the prior year.
  • Current Taxes reached $101000.0 in Q3 2025 per IONS's latest filing, up from $81000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $31.1 million in Q3 2023 and bottomed at $14000.0 in Q2 2022.
  • Average Current Taxes over 5 years is $4.7 million, with a median of $450000.0 recorded in 2021.
  • Peak YoY movement for Current Taxes: skyrocketed 194087.5% in 2023, then plummeted 99.87% in 2024.
  • A 5-year view of Current Taxes shows it stood at $36000.0 in 2021, then soared by 17258.33% to $6.2 million in 2022, then plummeted by 65.58% to $2.2 million in 2023, then plummeted by 98.42% to $34000.0 in 2024, then skyrocketed by 197.06% to $101000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $101000.0 in Q3 2025, $81000.0 in Q2 2025, and $126000.0 in Q1 2025.